Drugmakers' Finance Costs Jump 47% Amid High Interest Rates ▼ × Advertise with us Monday, July 27, 2026 Most
Widely Read Newspaper Subscribe: Punch E-Paper Subscribe: Punch E-Paper Home News Featured 2026 World Cup Metro Plus
Business Sports HealthWise Editorial Columns Videos Continuation From Print PunchNG Menu: Politics Spice Special
Features Education Sex & Relationship Interview Columns Opinion Advertise with us Drugmakers’ finance costs jump
47% amid high interest rates July 26, 2026 5:00 am Industrial Pharmaceutical Supply Chain. Photo: ASC Software By
Arinze Nwafor Kindly share this story: Nigerian pharmaceutical companies listed on the Nigerian Exchange recorded a 46.5
per cent increase in combined finance costs in the first quarter of 2026, as high interest rates and growing reliance on
debt continued to squeeze profitability across the sector. For stock market-listed companies, finance costs (also called
finance expenses or borrowing costs) are the expenses a company incurs from financing its operations through debt and
certain financial obligations. They are reported in the income statement and are deducted from operating profit to
arrive at profit before tax. An analysis of unaudited first-quarter results by Sunday PUNCH showed that the combined
finance costs of MeCure Industries Plc, Neimeth International Pharmaceuticals Plc and Morison Industries Plc rose from
N2.09bn in the first quarter of 2025 to N3.07bn in the corresponding period of 2026, an increase of N972.96m. The rise
came amid a mixed bag of results for the companies, with some posting strong profit growth while others recorded
near-stagnant earnings. MeCure led the pack in both revenue and finance cost growth. The company’s finance cost rose
by 49.5 per cent, from N1.75bn to N2.62bn, even as its operating profit nearly doubled from N2.57bn to N4.54bn within
the same period. Neimeth’s finance cost climbed by 31.6 per cent, from N334.1m to N439.5m, while its profit after tax
grew marginally from N105.5m to N113.4m. Morison Industries, on the other hand, kept its finance expenses flat at N4.86m
but still posted a loss of N8.16m for the quarter, an improvement from the N18.55m loss recorded in the same period of
2025. Beyond debt servicing, the companies also expanded investment in fixed assets during the period. Fidson Healthcare
Plc grew its property, plant and equipment by 12.9 per cent, from N30.94bn to N34.93bn, within a single quarter, while
MeCure’s fixed assets rose by 9.3 per cent to N44.41bn. May & Baker Nigeria Plc’s fixed assets, on a
year-on-year basis, grew by 24.1 per cent. In separate telephone interviews with Sunday PUNCH, experts, including the
Chief Executive Officer of the Centre for the Promotion of Private Enterprise, Dr Muda Yusuf, said the rising finance
costs recorded by the companies largely reflected Nigeria’s high interest rate environment rather than operational
inefficiency. “Anywhere we are seeing high finance costs is largely as a result of the high interest rate regime.
Because if MPR is at 26.5, what do you expect as far as financing costs are concerned?” Dr Yusuf queried. He explained
that companies typically prefer equity financing to debt financing because of the cost of borrowing, and that firms
which reported lower finance costs may have chosen to reinvest profits instead of taking on new loans. “I believe that
some of them have opted for more equity financing or reinvesting some of their profits to reduce borrowing costs, which
may have been responsible for the lower borrowing costs that you saw in some of those industries,” Dr Yusuf said.
Meanwhile, the Manufacturers Association of Nigeria, in its Manufacturing State of Affairs 2025 report, repeatedly
warned of the risks high interest rates pose to industrialisation in the country. Related News Linkage Assurance
concludes N16.2bn rights issue, boosts capital Banks’ maximum lending rate drops to 33.16% Businesses split over
borrowing costs, access to credit The group projected that in 2026: “The CBN is anticipated to implement further cuts
in the benchmark interest rate to about 23 per cent, in line with the disinflationary trend and to stimulate credit
expansion and output growth.” That expectation remains unmet, as the Monetary Policy Committee retained the benchmark
interest rate at 26.5 per cent after its meeting on July 21 and 22. Yusuf also linked the improved performance of
pharmaceutical firms to government fiscal incentives, including import duty concessions on raw materials and
intermediate products granted to cushion the effects of economic reforms. “The pharmaceutical companies were part of
the beneficiaries of those import duty concessions, which meant that their costs had come down, and which has also
increased their profitability,” the CPPE CEO remarked. He added that the naira’s exchange rate stability had pushed
up the cost of imported drugs, prompting more Nigerians to switch to locally manufactured alternatives, a shift that has
benefited domestic pharmaceutical manufacturers. “Most Nigerians are buying mainly Nigerian drugs and imported ones,
largely because of cost. And that has benefited those pharmaceutical companies,” Yusuf said. Taking a different
perspective, Professor of Economics and Public Policy at the University of Uyo, Akpan Ekpo, said the rising finance
costs also reflected broader structural challenges in the operating environment, particularly the cost of alternative
power supply. “When firms spend a lot of money to generate power, it will increase the cost of doing business,” Ekpo
said. He noted that Nigeria’s continued reliance on generators, in the absence of stable grid electricity, had
continued to inflate operating costs for manufacturers, including pharmaceutical companies. “Nigeria is still in a
generator-driven economy, and it’s affecting companies,” Ekpo said. He said government intervention, such as
dedicating power supply to industrial clusters, could help reduce the cost of doing business for manufacturers, adding
that exchange rate policy also played a significant role in determining company costs. “If the company is involved
with importing inputs and they need forex, and the exchange rate is stable, but it’s stable at a higher level for the
nature of our economy, so the company will spend more now to get dollars,” Ekpo said. What the rising finance costs
recorded by the companies represent may be either sound leveraged investment or a warning sign, depending largely on
whether operating profit is growing fast enough to justify the additional debt burden. MeCure’s near doubling of
operating profit alongside its 49.5 per cent rise in finance cost suggests the company’s borrowing is being
comfortably serviced by growth in its core business. Fidson’s balance sheet, by contrast, shows a sharp rise in
short-term borrowing and overdraft facilities alongside a decline in cash reserves, a pattern more consistent with
liquidity pressure than expansion-driven investment. Arinze Nwafor Arinze Nwafor is a journalist at Punch Newspapers
with five years of experience reporting on Nigeria’s economy, industry, data, metro, and judiciary. He focuses on
highlighting growth, policy, and market challenges shaping Africa’s largest economy. Arinze’s reporting reflects
practical newsroom experience, editorial judgment, and a strong commitment to accurate, informative, and
audience-focused journalism. Kindly share this story: All rights reserved. This material, and other digital content on
this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior
express written permission from PUNCH. Contact: [email protected] NEWS UPDATE: Nigerians can now earn as much as
$15,000- $25,000 with premium domains. You decide if you want payment in Naira or US Dollars. Be sure to ask for
evidence and proof of people benefitting daily from this. CLICK HERE TO START. Click here to start. —-> Stay informed
and ahead of the curve! Follow The Punch Newspaper on WhatsApp for real-time updates, breaking news, and exclusive
content. Don't miss a headline – join now! Join The Punch Newspapers Channel Stay in the know—fast. Get instant
alerts, breaking headlines, and exclusive stories with the Punch News App. Download now and never miss a beat. Get the
Punch News App Read PUNCH Anywhere Unlock the full print replica on any device - every page, every day. Subscribe now
for instant e-edition access. Subscribe Latest News 28 minutes ago Chelsea starting new season with good energy, says
Alonso 56 minutes ago Russian brand deal purely commercial, says ex-Italy midfielder Pirlo 1 hour ago Dangote blames
importers for petrol sales policy reversal 1 hour ago Suspect confesses to Falcons hotel heist 1 hour ago Fake agency
scandal: Reps grill Accountant-General today Top News Opposition splits over single candidate to challenge Tinubu July
27, 2026 1:20 am Obasanjo’s role in Obi-Kwankwaso ticket sparks row APC drafts Omisore into 276-member Osun gov
campaign council Hoodlums invade Osun INEC office, cart away PVCs FG raises varsity workers’ hazard allowance to
N486,000 K1's saxophonist apologises over viral 'unnecessary pregnancy' controversial song Why Buhari didn’t openly
support Tinubu in 2023 APC primary — Ex-SGF Babachir Why I chose Burna Boy for World Cup anthem — Shakira Voter
registration: INEC ends exercise today as opposition demands extension I’ve seen five families wiped out in Plateau
attacks — Berom youth leader News Sports Metro Plus Politics Featured Latest News Business Business & Economy
Opinion Entertainment Auto Famous Barka Da Sallah Barrier Breakers Breaking News Brexit Columns Corona Anti-corruption
Biafra Boko Haram Case Review Court News Court Trivia Campus Champion Celebrity City round Interview Panorama Opinion
Special Features Spice Technology Famous Parent Education Cartoon Columns Diaspora Advertise Subscribe Affiliate
Disclaimer News Sports Metro Plus Business Business & Economy Featured Politics Entertainment Uncategorized Latest
News Subscribe punchng.com © 1971- 2026 Punch Nigeria Limited About us Advertise with us Contact Privacy Policy
Casino Non AAMS Norsk casino Najlepsze kasyna online Casino Uden Rofus ▲
